Cannabis Bioscience International Holdings, Inc.
CBIH
Rank in Stocks
#32323
China Infrastructure Construction Corp. delivers specialized education focusing... China Infrastructure Construction Corp. delivers specialized education focusing on medical cannabis to audiences in the United States and Latin America, while also reaching a global market through its online programs. The company further extends its services to therapeutic areas, including supporting clinical trials and offering focused treatment for sleep disorders, specifically those linked to infertility, all managed through its fertility and sleep center located in Houston, Texas. Its Pharmacology University division broadens this scope by providing consulting, digital publishing, marketing, and franchising opportunities, alongside additional educational content related to medical cannabis. Founded in 2003, the organization's main operational hub is situated in Houston, Texas.
Share Price
$0.00015
Last synced: 2026-11-06
Market Cap
$1.74M
Change (1 day)
0.00%
Change (1 year)
-75.00%
Country
Stock data: Financial Modeling PrepΒ·Updated Β·Not investment adviceΒ·How we calculate this
Trade Cannabis Bioscience International Holdings, Inc. (CBIH)
Category
Healthcare
Operating Margin for Cannabis Bioscience International Holdings, Inc. (CBIH)
Operating Margin as of November 2026 TTM: -312.80%
According to Cannabis Bioscience International Holdings, Inc.'s latest financial reports, its current operating margin (TTM) is -312.80%. At the end of 2025 the company had an operating margin of -139.05%.
Operating Margin history for Cannabis Bioscience International Holdings, Inc. from 2006 to 2026
Operating Margin at the end of each year
| Year | Operating Margin | Change |
|---|---|---|
| 2026 (TTM) | -312.80% | 124.96% |
| 2025 | -139.05% | -28.82% |
| 2024 | -195.36% | -37.06% |
| 2023 | -310.38% | -24.86% |
| 2022 | -413.09% | 2,637.51% |
| 2021 | -15.09% | -61.74% |
| 2020 | -39.44% | 1,323.83% |
| 2019 | -2.77% | -99.91% |
| 2018 | -3,245.16% | -19,033.26% |
| 2011 | 17.14% | -10.26% |
| 2010 | 19.10% | 15.20% |
| 2009 | 16.58% | 23.82% |
| 2007 | 13.39% | -112.69% |
| 2006 | -105.50% | 0.00% |
Operating Margin for similar companies or competitors
| Company | Operating Margin | Operating Margin Difference | Country |
|---|---|---|---|
| 19.41% | -100.06% |
DE
|
|
| 19.68% | -100.06% |
DE
|
|
| 13.26% | -100.04% |
JP
|
|
| 17.08% | -100.05% |
CH
|
|
| 14.92% | -100.05% |
IL
|
What is a company's Operating Margin?
The operating margin is a key indicator to assess the profitability of a company. Higher operating margins are generaly better as they show that a company is able to sell its products or services for much more than their production costs. The operating margin is calculated by dividing a company's earnings by its revenue.
Questions about Cannabis Bioscience International Holdings, Inc.'s operating margin
What is Cannabis Bioscience International Holdings, Inc.'s operating margin?
Cannabis Bioscience International Holdings, Inc.'s operating margin is -312.80%, as of Nov 2026.
What was Cannabis Bioscience International Holdings, Inc.'s operating margin in 2025?
In 2025, Cannabis Bioscience International Holdings, Inc.'s operating margin was -139.05%, compared with -195.36% in 2024.
How has Cannabis Bioscience International Holdings, Inc.'s operating margin changed since 2020?
From 2020 to 2025, Cannabis Bioscience International Holdings, Inc.'s operating margin was highest in 2021 (-15.09%) and lowest in 2022 (-413.09%).
How does Cannabis Bioscience International Holdings, Inc.'s operating margin compare with similar companies?
Cannabis Bioscience International Holdings, Inc.'s operating margin (-312.80%) is lower than that of all 5 similar companies listed above. The highest among them is Merck KGaA, with 19.68%.